Haemonetics (HAE) Misses Q2 EPS by 1c, Lowers FY EPS Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $101.95 -1.09%
Revenue Growth %: +5.5%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: +5.5%
Financial Fact:
Income before provision for income taxes: 22.83M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.60, $0.01 worse than the analyst estimate of $0.61. Revenue for the quarter came in at $239.9 million versus the consensus estimate of $239.99 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.40-$2.65, versus the consensus of $2.76.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
- GitLab’s second-quarter revenue jumps 21% as AI demand drives bookings
- EU opens antidumping review of Chinese silicon metal imports
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
